Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
Citi
Cipla
Teva
Merck
Argus Health
McKinsey
Fuji
Healthtrust

Generated: May 21, 2018

DrugPatentWatch Database Preview

Nebivolol hydrochloride; valsartan - Generic Drug Details

or, see our see our flat-rate plans

« Back to Dashboard

What are the generic sources for nebivolol hydrochloride; valsartan and what is the scope of nebivolol hydrochloride; valsartan freedom to operate?

Nebivolol hydrochloride; valsartan
is the generic ingredient in one branded drug marketed by Allergan Sales Llc and is included in one NDA. There are two patents protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.

Nebivolol hydrochloride; valsartan has thirty-seven patent family members in fifteen countries.

There are fourteen drug master file entries for nebivolol hydrochloride; valsartan. One supplier is listed for this compound.
Summary for nebivolol hydrochloride; valsartan
International Patents:37
US Patents:2
Tradenames:1
Applicants:1
NDAs:1
Drug Master File Entries: 14
Suppliers / Packagers: 1
Clinical Trials: 339
DailyMed Link:nebivolol hydrochloride; valsartan at DailyMed
Pharmacology for nebivolol hydrochloride; valsartan

US Patents and Regulatory Information for nebivolol hydrochloride; valsartan

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Allergan Sales Llc BYVALSON nebivolol hydrochloride; valsartan TABLET;ORAL 206302-001 Jun 3, 2016 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Allergan Sales Llc BYVALSON nebivolol hydrochloride; valsartan TABLET;ORAL 206302-001 Jun 3, 2016 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Allergan Sales Llc BYVALSON nebivolol hydrochloride; valsartan TABLET;ORAL 206302-001 Jun 3, 2016 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial Y ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

Supplementary Protection Certificates for nebivolol hydrochloride; valsartan

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
C/GB96/048 United Kingdom ➤ Try a Free Trial PRODUCT NAME: NEBIVOLOL, OPTIONALLY IN THE FORM OF A PHARMACEUTICALLY ACCEPTABLE SALT OR HYDRATE; REGISTERED: NL RVG/19317 19951018; UK 00242/0309 19960509
Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Julphar
US Army
Cipla
Medtronic
Colorcon
Argus Health
Dow
UBS
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.